Two separate research teams used base editing to make single-nucleotide changes in human embryos this month, targeting genes ...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it has completed enrollment in the pivotal cohort (Cohort 1) of the global Phase 3 REVEAL study evaluating obudanersen (ION582), an ...
For many years, doctors have struggled because pancreatic cancer usually causes few symptoms in its early stages. By the time ...